Cargando…

Pharmacognostic Assesment of the Endemic and Vulnerable Medicinal Climber-Cayratia pedata (Lam.) Gagnep. var. glabra Gamble and Its Antibacterial Activity

OBJECTIVE: The objective of this study is to evaluate a meticulous pharmacognostic cram is to supplement constructive information with regard to its identification, characterization, and standardization of endemic and endangered medicinal climber Cayratia pedata var. glabra and also screening the an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharmila, S., Kalaichelvi, K., Dhivya, S. M., Premamalini, P., Abirami, P., Jayanthi, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757322/
https://www.ncbi.nlm.nih.gov/pubmed/29333039
http://dx.doi.org/10.4103/pr.pr_25_17
_version_ 1783290836984791040
author Sharmila, S.
Kalaichelvi, K.
Dhivya, S. M.
Premamalini, P.
Abirami, P.
Jayanthi, G.
author_facet Sharmila, S.
Kalaichelvi, K.
Dhivya, S. M.
Premamalini, P.
Abirami, P.
Jayanthi, G.
author_sort Sharmila, S.
collection PubMed
description OBJECTIVE: The objective of this study is to evaluate a meticulous pharmacognostic cram is to supplement constructive information with regard to its identification, characterization, and standardization of endemic and endangered medicinal climber Cayratia pedata var. glabra and also screening the antibacterial activity of this climber. MATERIALS AND METHODS: The morphological characters of study plant, microscopic examination of leaf powder, anatomy of young stem, physicochemical analysis of plant powder, extractive values, phytochemical analysis, powder with different chemical reagents, fluorescence analysis of plant powder, and other World Health Organization (WHO) recommended for standardization were analyzed. The antibacterial activity of this study plant is also analyzed. RESULTS: C. pedata var. glabra belongs to the family Vitaceae, commonly known as “Kattuppirandai” is one such endemic and endangered species in Thaisholai, Nilgiris South Division, Western Ghats. With the patronage of veteran ethnic group traditional knowledge of this region, the species C. pedata var. glabra was selected for the pharmacognostical examination and antibacterial screening. There were no pharmacognostical reports of this plant, specifically to determine the anatomical and other physicochemical standards required for its quality control. The current study deals with pharmacognostical parameters for the aerial parts of study plant, which mainly consists of macromorphological and microanatomical characters, physicochemical constants (ash values and extractive values), fluorescence analysis, and phytochemical screening, one of the WHO accepted parameter for the identification of medicinal plants. The pharmacognostical exploration was undertaken for this species with the purpose of sketch the pharmacopeial standards. The antibacterial activity of this plant confirms the therapeutic power. CONCLUSION: The information obtained from pharmacognostical studies will be of used for supplementary pharmacological and therapeutical evaluation of the species and will assist in standardization for quality, purity, and authentication with the help, of which adulteration and substitution can be prevented. The antibacterial activity of this plant confirm the traditional knowledge of local healers on the wound healing property of this species and also suggest this plant species can be used as a promising source for the development of new pharmaceuticals that address the therapeutic needs to cure infectious diseases. SUMMARY: The species C. pedata var. glabra was selected for present research work, since this species is listed in Red data book and has a wider use for different ailments among the tribal population of Thiashola due to its high medicinal value. Pharmacognostical profile was generated from macroscopical analysis, microscopical studies, powder analysis, physico-chemical constituent values, fluorescence analysis and preliminary phytochemical evaluation. The antibacterial activity of this plant confirms the therapeutic power. [Image: see text] Abbreviations Used: WHO: World Health Organization; IUCN: International Union for the Conservation of Nature.
format Online
Article
Text
id pubmed-5757322
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-57573222018-01-12 Pharmacognostic Assesment of the Endemic and Vulnerable Medicinal Climber-Cayratia pedata (Lam.) Gagnep. var. glabra Gamble and Its Antibacterial Activity Sharmila, S. Kalaichelvi, K. Dhivya, S. M. Premamalini, P. Abirami, P. Jayanthi, G. Pharmacognosy Res Original Article OBJECTIVE: The objective of this study is to evaluate a meticulous pharmacognostic cram is to supplement constructive information with regard to its identification, characterization, and standardization of endemic and endangered medicinal climber Cayratia pedata var. glabra and also screening the antibacterial activity of this climber. MATERIALS AND METHODS: The morphological characters of study plant, microscopic examination of leaf powder, anatomy of young stem, physicochemical analysis of plant powder, extractive values, phytochemical analysis, powder with different chemical reagents, fluorescence analysis of plant powder, and other World Health Organization (WHO) recommended for standardization were analyzed. The antibacterial activity of this study plant is also analyzed. RESULTS: C. pedata var. glabra belongs to the family Vitaceae, commonly known as “Kattuppirandai” is one such endemic and endangered species in Thaisholai, Nilgiris South Division, Western Ghats. With the patronage of veteran ethnic group traditional knowledge of this region, the species C. pedata var. glabra was selected for the pharmacognostical examination and antibacterial screening. There were no pharmacognostical reports of this plant, specifically to determine the anatomical and other physicochemical standards required for its quality control. The current study deals with pharmacognostical parameters for the aerial parts of study plant, which mainly consists of macromorphological and microanatomical characters, physicochemical constants (ash values and extractive values), fluorescence analysis, and phytochemical screening, one of the WHO accepted parameter for the identification of medicinal plants. The pharmacognostical exploration was undertaken for this species with the purpose of sketch the pharmacopeial standards. The antibacterial activity of this plant confirms the therapeutic power. CONCLUSION: The information obtained from pharmacognostical studies will be of used for supplementary pharmacological and therapeutical evaluation of the species and will assist in standardization for quality, purity, and authentication with the help, of which adulteration and substitution can be prevented. The antibacterial activity of this plant confirm the traditional knowledge of local healers on the wound healing property of this species and also suggest this plant species can be used as a promising source for the development of new pharmaceuticals that address the therapeutic needs to cure infectious diseases. SUMMARY: The species C. pedata var. glabra was selected for present research work, since this species is listed in Red data book and has a wider use for different ailments among the tribal population of Thiashola due to its high medicinal value. Pharmacognostical profile was generated from macroscopical analysis, microscopical studies, powder analysis, physico-chemical constituent values, fluorescence analysis and preliminary phytochemical evaluation. The antibacterial activity of this plant confirms the therapeutic power. [Image: see text] Abbreviations Used: WHO: World Health Organization; IUCN: International Union for the Conservation of Nature. Medknow Publications & Media Pvt Ltd 2017-12 /pmc/articles/PMC5757322/ /pubmed/29333039 http://dx.doi.org/10.4103/pr.pr_25_17 Text en Copyright: © 2017 Pharmacognosy Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sharmila, S.
Kalaichelvi, K.
Dhivya, S. M.
Premamalini, P.
Abirami, P.
Jayanthi, G.
Pharmacognostic Assesment of the Endemic and Vulnerable Medicinal Climber-Cayratia pedata (Lam.) Gagnep. var. glabra Gamble and Its Antibacterial Activity
title Pharmacognostic Assesment of the Endemic and Vulnerable Medicinal Climber-Cayratia pedata (Lam.) Gagnep. var. glabra Gamble and Its Antibacterial Activity
title_full Pharmacognostic Assesment of the Endemic and Vulnerable Medicinal Climber-Cayratia pedata (Lam.) Gagnep. var. glabra Gamble and Its Antibacterial Activity
title_fullStr Pharmacognostic Assesment of the Endemic and Vulnerable Medicinal Climber-Cayratia pedata (Lam.) Gagnep. var. glabra Gamble and Its Antibacterial Activity
title_full_unstemmed Pharmacognostic Assesment of the Endemic and Vulnerable Medicinal Climber-Cayratia pedata (Lam.) Gagnep. var. glabra Gamble and Its Antibacterial Activity
title_short Pharmacognostic Assesment of the Endemic and Vulnerable Medicinal Climber-Cayratia pedata (Lam.) Gagnep. var. glabra Gamble and Its Antibacterial Activity
title_sort pharmacognostic assesment of the endemic and vulnerable medicinal climber-cayratia pedata (lam.) gagnep. var. glabra gamble and its antibacterial activity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757322/
https://www.ncbi.nlm.nih.gov/pubmed/29333039
http://dx.doi.org/10.4103/pr.pr_25_17
work_keys_str_mv AT sharmilas pharmacognosticassesmentoftheendemicandvulnerablemedicinalclimbercayratiapedatalamgagnepvarglabragambleanditsantibacterialactivity
AT kalaichelvik pharmacognosticassesmentoftheendemicandvulnerablemedicinalclimbercayratiapedatalamgagnepvarglabragambleanditsantibacterialactivity
AT dhivyasm pharmacognosticassesmentoftheendemicandvulnerablemedicinalclimbercayratiapedatalamgagnepvarglabragambleanditsantibacterialactivity
AT premamalinip pharmacognosticassesmentoftheendemicandvulnerablemedicinalclimbercayratiapedatalamgagnepvarglabragambleanditsantibacterialactivity
AT abiramip pharmacognosticassesmentoftheendemicandvulnerablemedicinalclimbercayratiapedatalamgagnepvarglabragambleanditsantibacterialactivity
AT jayanthig pharmacognosticassesmentoftheendemicandvulnerablemedicinalclimbercayratiapedatalamgagnepvarglabragambleanditsantibacterialactivity